FAP and cancer: The first study that retrospectively analyzed the activity of FAP in the hearts of a larger collective of patients was published by Heckmann et al. and comprised a total of 229 patients with metastasized cancer in a modeling (185 patients) and a confirmatory cohort (44 patients) [5].